Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Maybe the company should look at this
View:
Post by scarlet1967 on Oct 10, 2020 10:36am

Maybe the company should look at this

Comment by scarlet1967 on Oct 10, 2020 10:39am
I send it to Leah...
Comment by qwerty22 on Oct 10, 2020 12:29pm
Stanley and GH and Novo Nordisk. That's an interesting combo
Comment by scarlet1967 on Oct 10, 2020 12:31pm
That's why I send it to Leah. 
Comment by qwerty22 on Oct 10, 2020 12:35pm
I mean if Novo Nordisk entered the NASH space with rGH that's effectively a validation of Theratech's approach.We can argue the pros and cons of rGH versus GHRH and probably win but aside from that it should give greater strength to any GH based approach.
Comment by scarlet1967 on Oct 10, 2020 12:47pm
I didn't purchase the article but it is seems TH should look into it for their cause also Stanley previously working with Grinspoon now on NN's payroll?!
Comment by qwerty22 on Oct 10, 2020 12:54pm
"This work was supported by an investigatorinitiated research grant to Dr Stanley from Novo Nordisk, Inc Novo Nordisk had no role in the performance of the study, the analysis of data or the preparation or approval of this manuscript. This work was also supported in part by P30DK040561 (TLS) and 1K23HD100266 (LTF)." Just the usual academic/industry collaboration, she's still an ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse